HSK-37251

N/A

Report date: 2023/04/06 14:35:19
NME

Base Information

Drug NameHSK-37251
Drug Alias NameHSK37251HSK-37251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHisco Pharmaceutical (Meishan) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHisco Pharmaceutical (Meishan) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A